Having demonstrated EpCAM-AF680 to be useful for preclinical imaging of cell line-based orthotopic xenograft models of endometrial carcinoma, the goal was to apply this imaging strategy to monitor tumor development in PDX models. The gene discussed is EPCAM; the disease is endometrial carcinoma.